Hantavirus Pulmonary Syndrome: The First 100 US Cases

Abstract

In the spring of 1993, hantavirus pulmonary syndrome (HPS) "emerged" in the southwestern United States, where a multiagency investigation led to the rapid description of this new clinical entity and its etiology. Analysis of the first 100 US cases identified showed that the disease was distributed in 21 states, had gone unrecognized since at least 1959, and had a distinct spring-early summer seasonality. Of the infected persons, 54% were male; 63% were Caucasian, 35% were Native American, and 2% were African American. The average age of case-patients was 34.9 years, and 8 were children or adolescents aged < or = 16 years. The overall case-fatality rate was 52%. There was a 91% concordance among serologic, immunohistochemical, and molecular results. HPS in the United States is caused by at least three newly described pathogenic hantaviruses, each of which has a distinct rodent host, and cases of HPS have been recently recognized in Canada and South America. National surveillance of this sporadic disease remains essential for further defining the epidemiology and clinical spectrum.

Seoul Virus Infection in a Wisconsin Patient with Recent Travel to China, March 2009: First Documented Case in the Midwestern United States

“…However, Seoul virus has been detected among rat populations in port cities worldwide, including cities in the United States. 4,[10][11][12] In 2009, the first case of a domestically acquired Seoul virus infection was reported in Maryland in a patient who worked in an underground service tunnel where he might have had rodent contact. 5 In one study of wild rats trapped in Baltimore, nearly half the rats had detectable antibody against Seoul virus.…”

Síndrome cardiopulmonar por hantavírus no Triângulo Mineiro e Alto Paranaíba, Minas Gerais, 1998-2005: aspectos clínico-epidemiológicos de 23 casos

“…A ocorrência de hipoalbuminemia em 100% dos casos sugere que um resultado normal desta proteína acarreta menor possibilidade do diagnóstico de SCPH 7 . Um estudo dos 100 primeiros casos de SCPH ocorridos nos Estados Unidos, nos anos 90, mostrou que 65 (84%) de 77 pacientes necessitaram de intubação, uma proporção mais alta que os 10 (55,5%) dos 18 pacientes que necessitaram deste suporte em nosso estudo 10 . A associação significante entre o tipo de suporte respiratório utilizado e a sobrevida dos pacientes revelou que dentre aqueles que foram submetidos �� ventilação invasiva, grande parte evoluiu para o óbito, demonstrando que a instituição desta medida, tardiamente, não influi significativamente no prognóstico de pacientes gravemente comprometidos.…”

An Outbreak of Hantavirus Pulmonary Syndrome, Chile, 1997

“…HPS is characterized by fever, myalgia, gastrointestinal symptoms, and headache, with subsequent characteristic cardiopulmonary dysfunction and a 40% to 60% case-fatality rate (3). Although the etiologic agent, Sin Nombre virus (SNV), causes clinical symptoms that appear different from those that Eurasian hantaviruses cause in hemorrhagic fever with renal syndrome, SNV shares many features with these Old World hantaviruses (4,5), including an association with a single primary rodent host (Peromyscus maniculatus [deer mouse] in the case of SNV), which acts as the natural reservoir (6).…”